Anti-Acetylcholinesterase Activity of Commercially Important Ceylon Black Tea (Camellia sinensis L.) Grades Belonging to Different Elevations: Potential Natural Product for Type 3 Diabetes Management?
Asian Food Science Journal,
Aims: Sri Lankan tea which is known as the Ceylon tea is the world’s finest tea. Currently Sri Lanka remains as the second main black tea (BT) exporter and the main orthodox BT exporter in the world. Although several pharmacological activities of Ceylon tea have been reported, its anti-acetylcholinesterase (AChE) activity which has a direct relationship with the management of Alzheimer's disease or type 3 diabetes has not reported to date. Further, there are no comprehensive studies on anti-AChE activity of tea world over. Present study evaluated anti-AChE activity of commercially important Ceylon BT grades belonging to different elevations.
Methodology: Freeze dried hot water extracts of Broken Orange Pekoe Fannings (BOPF), Orange Pekoe (OP) and Dust No.1 BT grades from low, mid and high grown elevations and a Ceylon green tea sample collected from the local market were studied for anti-AChE activity using 96 well micro plate-based assay (n=3 each).
Results: Results showed that all tested Ceylon tea had anti-AChE activity with varying degrees of potentials in a dose dependent manner. The mean IC50 values of BOPF, OP and Dust No. 1 tea grades at different elevations varied from 499.61±10.95 - 569.19±5.78, 598.80±24.95 - 677.81±6.61 and 509.44±3.81 - 621.39±3.29 µg/mL respectively. Interestingly, observed anti-AChE activity of black tea showed significant differences (P< 0.05) among elevations. The order of potency of BOPF, OP and Dust No:1 BT for anti-AChE activity at different elevations was low grown>high grown=mid grown, high grown=low grown>mid grown and mid grown>low grown>high grown respectively. Anti-AChE activity of Ceylon green (433.96 ± 5.95 µg/mL) tea was significantly high (P<0.05) compared to the tested BT and activities of all Ceylon tea were moderate compared to the reference standard Galantamine (IC50:2.52±0.17 µg/mL).
Conclusion: It is concluded that selected Ceylon BT grades had varying levels of anti-AChE activity and it varied with the elevations.
- Alzheimer's disease
- type 3 diabetes
- anti-acetylcholinesterase activity
- ceylon black and green tea
How to Cite
Ferreira-Vieira TH, Guimaraes IM, Silva FR, Ribeiro FM. Alzheimer's disease: Targeting the cholinergic system. Curr Neuropharmacol. 2016;14(1):101-15.
Dobson CM. Alzheimer’s disease: Addressing a twenty-first century plague. Rend. Lincei. 2015;26:251-62.
Dos Santos TC, Gomes TM, Pinto BAS, Camara AL, Paes AMA. Naturally occurring acetylcholinesterase inhibitors and their potential use for Alzheimer’s disease therapy. Front Pharmacol. 2018;9: 10.3389/fphar.2018.01192,
Mahdi O, Baharuldin MTH, Nor NHM, Chiroma SM, Jagadeesan S, Moklas MAM. Chemicals used for the induction of Alzheimer’s disease-like cognitive dysfunctions in rodents. Biomed Res and Ther. 2019;6(11): 10.15419/bmrat.v6i11.575.
Nunes-Tavares N, Santos LE, Stutz B, Brito-Moreira J, Klein WL, Ferreira ST, et al. Inhibition of Choline Acetyltransferase as a Mechanism for Cholinergic Dysfunction Induced by Amyloid- Peptide Oligomers. J Biol Chem. 2012; 287(23):19377-19385.
Kroner Z. The relationship between Alzheimer's disease and diabetes: type 3 diabetes?. Altern Med Rev. 2009; 14(4):373-79.
Lee HJ, Seo HI, Cha HY, Yang YJ, Kwon SH, Yang SJ. Diabetes and Alzheimer's disease: mechanisms and nutritional aspects. Clin Nutr Res. 2018;7(4):229-40.
de la Monte SM, Wands JR. Alzheimer’s disease is type 3 diabetes-evidence reviewed. J Diabetes Sci Technol. 2008; 2(6):1101-13.
Sharma K. Cholinesterase inhibitors as Alzheimer's therapeutics. Mol Med Rep. 2019;20(2):1479-87.
Ali TB, Schleret TR, Reilly BM, Chen WY, Abagyan R. Adverse effects of cholinesterase inhibitors in dementia, according to the pharmacovigilance databases of the United-States and Canada. PLoS One. 2015;10(12): e0144337.
Lanctôt KL, Rajaram RD, Herrmann N. Therapy for Alzheimer's disease: how effective are current treatments?. Ther Adv Neurol Disord. 2009;2(3):163-80.
Ahmed F, Ghalib RM, Sasikala P, Ahmed KKM. Cholinesterase inhibitors from botanicals. Pharmacogn Rev. 2013; 7(14):121-30.
Murray AP, Faraoni MB, Castro MJ, Alza NP, Cavallaro V. Natural AChE inhibitors from plants and their contribution to Alzheimer’s disease therapy. Curr Neuropharmacol. 2013; 11(4):388-413.
Khan N, Mukhtar H. Tea and health: studies in humans. Curr Pharm Des. 2013;19(34):6141-47.
Modder WWD, Amarakooon AMT. Tea and Health. 1st ed. Talawakele: Tea Research Institute of Sri Lanka; 2002.
Chapagain AK, Hoekstra AY. The water needed to have the Dutch drink tea. Value of water research report series. no. 15. UNESCO-IHE, Netherlands, 2003.
Annual Report. Sri Lanka Tea Board, Colombo, Sri Lanka.1-106; 2017.
Ray S, De B. Acetylcholinesterase inhibitory properties of black tea and its polyphenolic components. Int J Pharm Pharm Sci. 2012;4(3):334-37.
Baranowska-Wójcik E, Szwajgier D, Winiarska-Mieczan A. Regardless of the brewing conditions, various types of tea are a source of acetylcholinesterase inhibitors. Nutrients. 2020;12(3):32155927.
Raghavendra HL, Kekuda TRP, Farhath K. Acetylcholinesterase inhibitory activity of green tea polyphenols. Sci Technol Arts Res J. 2014;3(4):141-42.
Jazayeri SB, Amanlou A, Ghanadian N, Pasalar P, Amanlou M. A preliminary investigation of anticholinesterase activity of some Iranian medicinal plants commonly used in traditional medicine. DARU J Pharm Sci. 2014; 22(1):10.1186/2008-2231-22-17.
Okello EJ, Leylabib R, McDougall GJ. Inhibition of acetylcholinesterase by green and white tea and their simulated intestinal metabolites. Food Funct. 2012;3(6):651- 61.
Hayat K, Iqbal H, Malik U, Bilal U, Mushtaq S. Tea and its consumption: benefits and risks. Crit Rev Food Sci Nutr. 2015;55(7):939-54.
Okello EJ, Mather J. Comparative kinetics of acetyl- and butyryl-cholinesterase inhibition by green tea catechins| Relevance to the symptomatic treatment of Alzheimer's disease. Nutrients. 2020;12(4): 32326457.
Han WY, Huang JG, Li X, Li ZX, Ahammed GJ, Yan P, et al. Altitudinal effects on the quality of green tea in east China: a climate change perspective. Eur Food Res Technol. 2017;243:323- 330.
Ratnasooriya WD, Ratnasooriya SG, Dissanayake R. In vitro antibacterial activity of Sri Lankan orthodox black tea (Camellia sinensis L.) belonging to different agro-climatic elevations. J Coast Life Med. 2016;4(8):623-27.
Ratnasooriya WD, Ratnasooriya SG, Ratnasooriya CDT, Dissanayake R. In vitro antifungal activity against Candida species of Sri Lankan orthodox black tea (Camellia sinensis L.) belonging to different agro-climatic elevations. J Coast Life Med. 2017;5(2):66-9.
Peterson J, Dwyer J, Jacques P, Rand W, Prior R, Chui K. Tea variety and brewing techniques influence flavonoid content of black tea. J Food Compost Anal. 2004;17(3-4):397-405.
Ratnasooriya WD, Abeysekera WPKM, Ratnasooriya CDT. In vitro anti-hyaluronidase activity of Sri Lankan low grown Orthodox Orange Pekoe grade black tea (Camellia sinensis L.). Asian Pac. J. Trop. Biomed. 2014;4(12):959-63.
Samaraweera DSA, Mohamed MTZ. Technology of tea processing. In: Handbook of tea. 1st ed. Sri Lanka: Tea Research Institute of Sri Lanka;2008.
Abeysekera WKSM, Ratnasooriya CTD, Ratnasooriya WD, Arachchige SPG. Sri Lankan black tea (Camellia sinensis L.) inhibits the methylglyoxal mediated protein glycation and potentiates its reversing activity in vitro. J Coast Life Med. 2016;4(2):148-53.
Ellman GL, Courtney KD, Jr. Andres V, Featherstone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol. 1961;7(2):88-90.
Lawrence AD, Sahakian BJ. The cognitive psychopharmacology of Alzheimer’s disease: focus on cholinergic systems. Neurochem Res. 1998;23(5):787-94.
Abeywickrama KRW, Amarakoon AMT, Ratnasooriya WD. In vitro and In vivo antioxidant activity of high grown Sri Lankan black tea (Camellia sinensis L). Sri Lanka J Tea Sci. 2005;709(2):57-68.
Ratnasooriya WD, Abeysekera WKSM, Muthunayake TBS, Ratnasooriya CDT. In vitro anti-glycation and cross-link breaking activities of Sri Lankan low grown Orthodox Orange Pekoe grade black tea (Camellia sinensis L.). Trop. J. Pharm. Res. 2014;13(4):567-71.
Ratnasooriya WD, Jayakody JRAC, Muthunayake TBS, Abeysekera WKSM, Ratnasooriya CDT. Glyceamic regulatory properties of Sri Lankan low grown Orthodox Orange Pekoe black tea (Camellia sinensis). Int J Pharm Res Anal. 2014;4(3):206-13.
Abeywickrama KRW, Ratnasooriya WD, Amarakoon AMT. Oral hypoglycaemic, antihyperglycaemic and antidiabetic activities of Sri Lankan Broken Orange Pekoe Fannings (BOPF) grade black tea (Camellia sinensis L.) in rats. J Ethnopharmacol. 2011;135(2):278-86.
Jayakody JRAC, Ratnasooriya WD. Blood glucose level lowering activity of Sri Lankan black tea brew (Camellia sinensis) in rats. Pharmacogn Mag. 2008;4(16):341-49.
Ratnasooriya WD, Fernando TSP, Madubashini PP. In vitro thrombolytic activity of Sri Lankan black tea, Camellia sinensis (L.) O. Kuntze. J Natl Sci Found Sri Lanka. 2008;36(2):179-81.
Ratnasooriya WD, Abeysekera WPKM, Ratnasooriya CDT. In vitro skin whitening and lightening properties of Sri Lankan low grown orthodox Orange Pekoe grade black tea. World J Pharm Sci. 2014;2(10):1249-52.
Ratnasooriya WD, Jayakody JRAC, Rosa SRD, Ratnasooriya CDT. In vitro sun screening activity of Sri Lankan Orthodox black tea (Camellia sinensis linn). World J Pharm Sci. 2014;2(2):144-48.
Ratnasooriya WD, Abeysekera WPKM, Ratnasooriya CTD. In vitro pancreatic lipase, cholesterol esterase, and cholesterol micellization inhibitory activity of Sri Lankan low grown Orthodox Orange Pekoe grade black tea (Camellia sinensis L.). J Coast Life Med. 2015; 3(7):570-74.
Abeywickrama KRW, Ratnasooriya WD, Amarakoon AMT. Oral diuretic activity of hot water infusion of Sri Lankan black tea (Camellia sinensis L.) in rats. Pharmacogn Mag. 2010; 24:271-77.
Ratnasooriya WD, Fernando TSP. Anti-diarrheal activity of Sri Lankan dust grade black tea (Camellia sinensis L.) in mice. Pharmacogn Mag. 2009;5(18):115-21.
Ratnasooriya WD, Fernando TSP. Anti-inflammatory activity of Sri Lankan black tea (Camellia sinensis L.) in rats. Pharmacogn Mag. 2009;1(1):11-20.
Ratnasooriya WD, Fernando TSP. Gastro protective activity of Camellia sinensis black tea brew in rats. Pharm Biol. 2009;47(8):675-82.
Ratnasooriya WD, Fernando TSP. Gastric ulcer healing activity of Sri Lankan black tea (Camellia sinensis L.) in rats. Pharmacogn Mag. 2009;5(19):260-65.
Ratnasooriya WD, Fernando TSP, Senevirathna CDWY. Anti-pyretic activity of Sri Lankan black tea. Sri Lanka J Tea Sci. 2007;72(2):54-60.
Ratnasooriya WD, Fernando TSP. Antinoceptive activity of Sri Lankan black tea brew (Camellia sinensis L.) in rats. Int. Res. J. Pharm. 2011;2(6):128-37.
Chen CN, Lin CPC, Huang KK, Chen WC, Hsieh HP, Liang PH, et al. Inhibition of SARS-CoV 3C-like Protease Activity by Theaflavin-3,3′-digallate (TF3). Evid Based Complement Alternat Med. 2005;2(2):209-15.
Jang M, Park YI, Cha YE, Park R, Namkoong S, Lee JI, et al. Tea polyphenols EGCG and theaflavin inhibit the activity of SARS-CoV-2 3CL-Protease in vitro. Evid Based Complement Alternat Med. 2020;ID 5630838.
Abstract View: 63 times
PDF Download: 20 times